Dr. Hu Baoyang is the Principal Investigator of Stem Cell Biology and Regenerative Medicine Lab at the Institute of Zoology, Chinese Academy of Sciences. He is currently the Executive Director of the Institute of Stem Cell and Regenerative, Chinese Academy of Science, the Executive Vice President of the Savaid Medical School of the University of Chinese Academy of Sciences and the deputy director of the State Key Laboratory of Stem Cell and Reproductive Biology.

Dr. Hu got his Ph. D degree in Fudan University in 2004. In 2005, Hu went to Dr. Su-Chun Zhang's stem cell research lab at the University of Wisconsin-Madison working on neural differentiation. He joined the Institute of Zoology at the Chinese Academy of Sciences in 2011.

Dr. Hu's lab focuses on brain development and disease, stem cell differentiation and clinical application, and has a series of important achievements in the evolutionary characteristics of brain development and regulation, the differentiation mechanism of the nervous system, and the clinical application of differentiated cells. Dr. Hu and his team discovered the heterogeneity and regularity of neural differentiated human iPS for the first time (PNAS, 2010), firstly acquired the SIRT6 knockout monkeys and revealed its regulatory and evolutionary properties (Nature, 2018), and took the head in promoting the Clinical studies of treating Parkinson's disease with hESC differentiation cell.

He has undertaken many scientific research projects of the Ministry of Science and Technology, the National Natural Science Foundation of Chinese, and the Chinese Academy of Sciences. He has published more than 40 prestigious papers in journals such as Nature, Science, Cell Stem Cells, PNAS, Cell Research, and won 2 US patents. He has served as a reviewer of various international academic journals and has been invited to participate in international and domestic academic exchanges. He is also the deputy head of the special expert group for stem cell and transformation research of the National Major Research and Development Program, the executive director of the Chinese Society of Cell Biology, and the director of the Stem Cell Branch.